期刊文献+

不同糖耐量人群血浆IL-18水平与胰岛素抵抗的相关性 被引量:7

Relationship between Plasma Interleukin-18 Levels and Insulin Resistance in Patients with Different Glucose Tolerance
下载PDF
导出
摘要 目的:探讨不同糖耐量人群血浆中白细胞介素-18(IL-18)水平变化与胰岛素抵抗的相关性。方法:收集2型糖尿病(T2DM,n=30)组、糖耐量减低(IGT,n=30)组及糖耐量正常(NGT,n=28)组相关临床资料,ELISA法测定血浆中IL-18水平,以胰岛素抵抗指数(HOMA-IR)作为估计胰岛素抵抗(IR)的指标,HOMA-IR分别与各代谢指标做Pearson相关分析,并对影响HOMA-IR的危险因素进行多元逐步回归分析。结果:T2DM及IGT组体重指数(BMI)、腰围、三酯甘油(TG)、HOMA-IR及IL-18等指标均显著高于NGT组,差异有统计学意义(P<0.01)。Pearson相关分析显示HOMA-IR与IL-18及BMI呈显著正相关(r分别为0.571、0.423,P<0.01),调整BMI后IL-18与HOMA-IR独立相关(r=0.50,P<0.01)。多元逐步回归分析,4个变量进入回归模型(P<0.05),分别为IL-18(Beta值:0.498)、BMI(Beta值:0.358)、TG(Beta值:0.353)、TC(Beta值:0.298)。结论:IL-18在IGT阶段已有显著增高,可能通过IR而参与了T2DM的发生和发展。 Objective: To investigate the relationship between plasma interleukin-18 (IL-18) levels and insulin resistance (IR) in patients with different glucose tolerance. Method: Eighty-eight people were divided into 3 groups including impaired glucose tolerance group ( group IGT, n = 30) , type-2 diabetes mellitus group( group T2DM, n = 30)and normal glucose tolerance group( group NGT, n = 28). Plasma IL-18 levels were measured by using ELISA. Homeostasis model assessment index of insulin resistance (HOMA-IR) was used as indicatrix reflecting IR level. Pearson's correlation analysis was carried out between HOMA-IR and other metabolic indexes, and multiple stepwise regression analysis was used to identify the influence of risk factors to IR. Results: Body mass index (BMI), Waistline, trigly- erde (TG), HOMA-IR and IL-18 were significantly higher in groups T2DM and IGT than in group NGT (P 〈0.01). Pearson's correlation analysis showed significant positive correlations occurred between plasma HOMA-IR and IL-18, and between HOMA-IR and BMI ( r =0. 571 ,and r =0. 423 respectively, P 〈0.01). Multiple stepwise regression analysis showed that IL-18, BMI, TG, and total cholesterol (TC) were independently associated with HOMA-IR, and the standard correlation coefficients were 0. 498, 0. 358, 0. 353, and 0. 298 respectively (P 〈 0.05 ). Conclusion : IL-18 level has increased in pre-diabetic stage, and might participate the pathogenesis and development of type 2 diabetes by affecting IR.
作者 赵星 方洁
出处 《贵阳医学院学报》 CAS 2009年第4期399-401,共3页 Journal of Guiyang Medical College
基金 贵州省卫生厅优秀医学青年科技人才基金资助(G2007-6)
关键词 糖尿病 白细胞介素-18 糖耐量减低 胰岛素抵抗 diabetes mellitus interleukin-18 impaired glucose tolerance insulin resistance
  • 相关文献

参考文献9

  • 1Wellen KE , Hotamisligil GS. Inflammation , stress , and diabetes [ J ]. J Clin Invest, 2005 ( 115 ) : 1111 - 1119.
  • 2李秀钧,邬云红.糖尿病是一种炎症性疾病?[J].中华内分泌代谢杂志,2003,19(4):251-253. 被引量:254
  • 3JA Gracie, SE Robertson, IB McInnes . Interleukin-18 [ J]. J Leukoc Biol,2003 (2) :213 - 224.
  • 4Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women : a randomized trial [ J ]. JAMA, 2003 (289) : 1799 - 1804.
  • 5Hector F Escobar-Morreale, Jose I Botella-Carretero. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome : relationship to insulin resistance and to obesity [ J ]. J Clin Endocrinol Metab, 2004 (2) :806 -811.
  • 6Thomas Skurk, Hubert Ko, Sylvia Muller-Scholzel ,et al. The proatherogenic cytokine interleukin-18 is secreted by human adipocytes [ J ]. Eur J Endocrinol, 2005 ( 152 ) : 863 - 868.
  • 7李伟民,傅祖植.肥胖的2型糖尿病患者血浆白细胞介素-18含量及其与胰岛素抵抗的关系[J].中国老年学杂志,2006,26(10):1332-1333. 被引量:2
  • 8Barbara Thorand, Hubert Kolb, Jens Baumert, et al. Elevated Levels of Interleukin-18 Predict the Development of Type 2 Diabetes [ J ]. DIABETES, 2005 ( 54 ) : 2932 - 2938.
  • 9Guebre XM, Yang S, Lin HZ, et al. Altered hepatic lymphocyte subpopulations in obesity related murine fatty livers: potentialmechanism for sensitization to liver damage [ J ]. Hepatology, 2000 (3) : 633 - 640.

二级参考文献26

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2126
  • 2Schmidt MI, Duncan BB, Scharrct AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet, 1999,353:1649-1652.
  • 3Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes, 2001,50:2384-2389.
  • 4Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 2001,286:327-334.
  • 5Festa A, Ralph BD, Russell PT, et al. Elevated levels of acute phase proteins and plasminogen activator inhibitor-1 (PAI-1) predict the development of type 2 diabetes mellitus: the insulin resistance atherosclerosis study (IRAS). Diabetes, 2000,49(Suppl 1):A24-A25.
  • 6Duncan BB, Schmidt MI, Offenbacher S, et al. Factor Ⅷ and other hemostasis variables are related to incident diabetes in adults. Diabetes care, 1999,22:767-772.
  • 7Lindsay RS, Krakoff J, Hanson RL, et al. Gamma globulin levels predict type 2 diabetes in the Pima Indian population. Diabetes, 2001,50:1598-1603.
  • 8Mcneely MJ, Bokyko EJ, Weigle DS, et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care, 1999,22:65-70.
  • 9Yuan M, Konstantopoulos N, Lee J, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKbeta. Science, 2001,293:1673-1677.
  • 10Hundal RS, Petersen KF, Mayerson AB, et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest, 2002,109:1321-1326.

共引文献254

同被引文献91

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部